Insights and Trends from 2021 FDA GCP Inspections

What You Will Learn

The FDA oversees clinical trials to ensure they are designed, conducted, analyzed and reported according to federal law and good clinical practice (GCP) regulations. Reviewing inspection observations and trends from 2021 can help clinical researchers determine common issues, highlight potential quality management gaps and identify improvement opportunities.

In this Expert Insights webinar, you’ll learn how to improve your quality systems and increase compliance as we will review FDA observations and trends from 2021 on:

• • 483 Observations
  • Warning Letters
  • Seizures
  • Trends & the R3 Draft